A Sample Guideline for Reverse Vaccinology Approach for the Development of Subunit Vaccine Using Varicella Zoster as a Model Disease
Author:
Cireli ElifORCID,
Çavaş LeventORCID
Reference60 articles.
1. Sette A, Rappuoli R (2010) Reverse vaccinology: developing vaccines in the era of genomics. Immunity 33(4):530–541. https://doi.org/10.1016/j.immuni.2010.09.017
2. Heidary M, Kaviar VH, Shirani M et al (2022) A comprehensive review of the protein subunit vaccines against COVID-19. Front Microbiol 13:927306. https://doi.org/10.3389/fmicb.2022.927306
3. Gao F, Huang J, Li T, Hu C et al (2021) A highly conserved peptide vaccine candidate activates both humoral and cellular immunity against SARS-CoV-2 variant strains. Front Immunol 12. https://doi.org/10.3389/fimmu.2021.789905
4. Vita R, Mahajan S, Overton JA, Dhanda SK, Martini S, Cantrell JR, Wheeler DK, Sette A, Peters B (2019) The Immune Epitope Database (IEDB): 2018 update. Nucleic Acids Res 47(D1):D339–D343. https://doi.org/10.1093/nar/gky1006
5. Boonyaratanakornkit J, Taylor JJ (2019) Techniques to study antigen-specific B cell responses. Front Immunol 10:1694. https://doi.org/10.3389/fimmu.2019.01694